Table 3. β2*-nAChR availability (VT/fP) throughout the Brain in Nonsmoker Controls and Smokers during Acute and Prolonged Abstinence.
| Nonsmoker | Smoker 1 day | Smoker 1 week | Smoker 2 weeks | Smoker 4 weeks | Smoker 6-12 weeks | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Region | VT/fP* | VT/fP | % Diff** | P† | VT/fP | % Diff | P | VT/fP | % Diff | P | VT/fP | % Diff | P | VT/fP | % Diff | P |
| Thalamus | 130.6±22.2 | 96.9±24.4 | -26% | .002 | 138.5±25.9 | +6% | .322 | 139.2±35.6 | +7% | .461 | 133.8±19.3 | +2% | .694 | 115.2±19.7 | -12% | .140 |
| Striatum | 70.0±11.0 | 66.5±13.1 | -5% | .492 | 85.1±16.8 | +22% | .002 | 80.9±18.2 | +16% | .070 | 79.5±12.6 | +14% | .037 | 71.7±13.3 | +2% | .760 |
| Parietal Cortex | 46.0±7.8 | 44.4±7.5 | -3% | .659 | 56.6±9.9 | +23% | .001 | 56.4±16.2 | +23% | .144 | 52.3±10.9 | +14% | .071 | 44.5±9.6 | -3% | .714 |
| Frontal Cortex | 51.0±8.6 | 47.9±10.8 | -6% | .450 | 61.8±13.0 | +21% | .005 | 60.9±15.9 | +19% | .158 | 58.3±13.8 | +14% | .078 | 49.1±12.9 | -4% | .685 |
| Anterior Cingulate | 52.5±7.8 | 54.8±7.7 | +4% | .511 | 67.5±12.2 | +29% | <.001 | 63.9±15.1 | +22% | .098 | 61.4±10.0 | +17% | .010 | 55.3±11.6 | +5% | .500 |
| Temporal Cortex | 57.7±8.7 | 57.4±10.4 | -1% | .941 | 70.2±12.8 | +22% | .001 | 67.5±15.3 | +17% | .048 | 66.1±9.7 | +15% | .021 | 58.2±11.6 | +1% | .908 |
| Occipital Cortex | 54.2±7.7 | 56.3±11.7 | -4% | .587 | 68.6±13.4 | +27% | .001 | 66.3±14.3 | +22% | .067 | 64.1±10.3 | +18% | .005 | 55.5±13.9 | +2% | .771 |
| Cerebellum | 62.9±8.5 | 59.5±18.4 | -5% | .649 | 77.9±15.5 | +24% | .002 | 74.0±17.0 | +18% | .143 | 73.2±11.5 | +16% | .009 | 60.6±13.5 | -4% | .605 |
VT/fP equals regional [123I]5-IA uptake (kBq/cc)/free plasma parent (kBq/mL);
Percent Difference from Nonsmokers = ((Smoker-Nonsmoker)/Nonsmoker)*100;
p-values <0.00625 are significant after Bonferroni's correction